• PPM-18 for NF-κB and iNOS Research

  2026-08-24

  PPM-18 enables a focused way to connect NF-κB activation with downstream iNOS expression, nitrite release, and inflammatory cytokines. This workflow-oriented guide covers cell-based inflammation assays, sepsis research considerations, practical controls, and troubleshooting for a chemically defined naphthoquinone derivative.

• SIRT4, Glutamine Metabolism, and Liver Fibrosis

  2026-08-23

  The reference study identifies a metabolic vulnerability in activated hepatic stellate cells: dependence on glutamine catabolism through glutamate dehydrogenase. Its central finding is that reduced SIRT4 activity permits GDH-driven production of α-ketoglutarate, supporting stellate-cell proliferation and fibrosis, whereas GDH inhibition or modest SIRT4 overexpression attenuates disease-associated responses.

• HyperScribe™ Poly (A) Tailing Kit Guide

  2026-08-22

  A scenario-based guide to using HyperScribe™ Poly (A) Tailing Kit, SKU K1053, to prepare translation-ready RNA for transfection and phenotype-focused experiments. It connects polyadenylation chemistry with practical controls for cell viability, proliferation, and cytotoxicity assays.

• Leucovorin Calcium in Tumor–Stroma Drug Testing

  2026-08-22

  Leucovorin Calcium, or calcium folinate, can serve as both a methotrexate-rescue reagent and a mechanistic control in patient-derived gastric cancer assembloids. This article outlines how translational teams can use folate biology, matched tumor–stroma models, and assay controls to interpret drug response and resistance more rigorously.

• Sodium salicylate as an NF-κB inhibitor in stroma research

  2026-08-21

  Sodium salicylate provides a practical small-molecule perturbation for linking NF-κB activity, oxidative stress, and stromal inflammation in cell and 3D tumor models. This workflow-oriented guide shows how to benchmark it against the sequential, stroma-remodeling nanomedicine reported in pancreatic cancer research without overstating what that study demonstrated.

• Atrial Natriuretic Peptide: Assay Guide

  2026-08-20

  A practical, scenario-based guide to using Atrial Natriuretic Peptide (ANP) (C49H84N20O15S), rat (SKU A1009) in cell viability, proliferation, and cytotoxicity workflows. It addresses formulation, storage, assay controls, data interpretation, and evidence-based vendor selection for cardiovascular and metabolic research.

• Angiotensin Peptides and SARS-CoV-2 Spike Binding

  2026-08-20

  The 2025 reference study shows that naturally occurring angiotensin peptides can increase SARS-CoV-2 spike-protein binding to host receptors, with the strongest effects associated with selected shorter or modified peptides. Its receptor-selective binding design connects renin-angiotensin system research with viral entry biology while also clarifying why these findings should not yet be interpreted as evidence of enhanced infection in vivo.

• Clathrin-Mediated GCRV Entry: Dynasore Evidence

  2026-08-19

  Wang et al. used pharmacological inhibition, transmission electron microscopy, and RT-qPCR to show that genotype III grass carp reovirus enters CIK cells through a dynamin-dependent, clathrin-mediated, acidified endosomal route. The study also distinguishes the replication kinetics of GCRV104 from genotype I GCRV-JX01 and identifies PI3K- and PKC-associated signaling as additional intervention points.

• VP26, MYH9, and Duck Enteritis Virus Replication

  2026-08-19

  A 2025 study used VP26 affinity purification and proteomics to identify host cytoskeletal proteins associated with duck enteritis virus, then validated MYH9 as a key interaction partner. Functional inhibition of actin polymerization or myosin II activity reduced viral titers, positioning the actin–myosin II network as an important host determinant of DEV proliferation.

• 5-Azacytidine Beyond Demethylation: A Translational Playbook

  2026-08-18

  5-Azacytidine is more than a DNA methylation tool: its value increasingly depends on cellular context, chromatin state, and immune competence. This thought-leadership guide connects DNMT trapping to viral mimicry, experimental design, and translational decision-making, with practical guidance for using 5-AzaC in cancer biology workflows.

• β-Pseudouridine in saRNA Assay Design

  2026-08-18

  β-Pseudouridine is the C-glycoside isomer of uridine with important implications for RNA modification research. This guide separates nucleoside chemistry from platform-level vaccine evidence and provides a practical framework for interpreting saRNA, mRNA, and translational assays.

• H. pylori–HNF4A Methylation Drives Gastric Cancer

  2026-08-17

  The reference study identifies promoter hypermethylation of HNF4A as a mechanistic link between Helicobacter pylori infection and gastric cancer progression. Its integrated clinical, single-cell, cellular, animal, methylation, and rescue analyses connect HNF4A silencing with epithelial polarity loss and TGFβ-associated EMT signaling, providing a framework for studying infection-driven epigenetic transformation.

• Valemetostat BA4816 for Reliable Cell Assays

  2026-08-17

  This scenario-based guide explains how Valemetostat (DS-3201; SKU BA4816) can improve the design, execution, and interpretation of cell viability, proliferation, and cytotoxicity assays. It connects EZH2-focused pharmacology with solvent control, dose-response modeling, and practical supplier-selection criteria.

• Cabazitaxel (XRP6258): Workflow and QC Guide

  2026-08-16

  Cabazitaxel (XRP6258, SKU B2157) provides a practical research tool for antiproliferative assays and taxane-resistant cancer models, including systems involving P-glycoprotein expression. It is water-insoluble, so workflows should use DMSO or ethanol stocks, prompt solution use, matched vehicle controls, and careful precipitation checks rather than direct aqueous preparation or long-term stock storage.

• H-Aggregated NIR-II Fluorophore for Cancer Therapy

  2026-08-15

  Yu et al. developed RRIALP-C4, a peptide-functionalized liposome that transfers H-aggregated IR-1061 from the carrier to tumor cell membranes. This design couples NIR-II fluorescence imaging with NIR-I photothermal therapy and carboplatin release, providing a mechanistic route to image-guided thermochemotherapy.

7883 records 1/526 page Next 12345 下5页 Last page